These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31048355)

  • 41. IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients.
    Yang YT; Hou HA; Liu CY; Lin CC; Chou WC; Lee FY; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Kuo YY; Huang SY; Ko BS; Chen CY; Hsu SC; Lin CT; Wu SJ; Tsay W; Chen YC; Tien HF
    Am J Hematol; 2014 Sep; 89(9):E142-9. PubMed ID: 24845799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monosomal karyotypes among 1147 Chinese patients with acute myeloid leukemia: prevalence, features and prognostic impact.
    Yang XF; Sun AN; Yin J; Cai CS; Tian XP; Qian J; Chen SN; Wu DP
    Asian Pac J Cancer Prev; 2012; 13(11):5421-6. PubMed ID: 23317194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ferrant A; Labopin M; Frassoni F; Prentice HG; Cahn JY; Blaise D; Reiffers J; Visani G; Sanz MA; Boogaerts MA; Löwenberg B; Gorin NC
    Blood; 1997 Oct; 90(8):2931-8. PubMed ID: 9376573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
    Mohr B; Schetelig J; Schäfer-Eckart K; Schmitz N; Hänel M; Rösler W; Frickhofen N; Link H; Neubauer A; Schuler U; Platzbecker U; Middeke JM; Ehninger G; Bornhäuser M; Schaich M; Stölzel F;
    Br J Haematol; 2013 Apr; 161(2):237-44. PubMed ID: 23432431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Daher-Reyes G; Kim T; Novitzky-Basso I; Kim KH; Smith A; Stockley T; Capochichi JM; Al-Shaibani Z; Pasic I; Law A; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Schimmer A; McNamara C; Murphy T; Maze D; Gupta V; Sibai H; Chan S; Yee K; Minden M; Zhang Z; Schuh A; Kim DDH
    Bone Marrow Transplant; 2021 Aug; 56(8):1908-1918. PubMed ID: 33767401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different prognosis of acute myeloid leukemia harboring monosomal karyotype with total or partial monosomies determined by FISH: retrospective PALG study.
    Wawrzyniak E; Wierzbowska A; Kotkowska A; Siemieniuk-Rys M; Robak T; Knopinska-Posluszny W; Klonowska A; Iliszko M; Woroniecka R; Pienkowska-Grela B; Ejduk A; Wach M; Duszenko E; Jaskowiec A; Jakobczyk M; Mucha B; Kosny J; Pluta A; Grosicki S; Holowiecki J; Haus O
    Leuk Res; 2013 Mar; 37(3):293-9. PubMed ID: 23254155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
    Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
    Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prognostic significance of monosomal karyotype in acute myeloid leukemia].
    Luan Y; Xu J; Huang B; Liu X; Liu Y; Chen L; Chu X
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):286-90. PubMed ID: 25916287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical and genetics characteristics of patients with monosomal karyotype acute myeloid leukemia patients].
    Cheng F; Ma X; Pan J; Wu Y; Zhang J; Xue Y; Wang Q; Yao H; Wen L; Shen Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Aug; 31(4):508-10. PubMed ID: 25119923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia.
    van Gelder M; de Wreede LC; Schetelig J; van Biezen A; Volin L; Maertens J; Robin M; Petersen E; de Witte T; Kröger N;
    Leukemia; 2013 Apr; 27(4):879-88. PubMed ID: 23164802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.
    Rücker FG; Schlenk RF; Bullinger L; Kayser S; Teleanu V; Kett H; Habdank M; Kugler CM; Holzmann K; Gaidzik VI; Paschka P; Held G; von Lilienfeld-Toal M; Lübbert M; Fröhling S; Zenz T; Krauter J; Schlegelberger B; Ganser A; Lichter P; Döhner K; Döhner H
    Blood; 2012 Mar; 119(9):2114-21. PubMed ID: 22186996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
    Visani G; Bernasconi P; Boni M; Castoldi GL; Ciolli S; Clavio M; Cox MC; Cuneo A; Del Poeta G; Dini D; Falzetti D; Fanin R; Gobbi M; Isidori A; Leoni F; Liso V; Malagola M; Martinelli G; Mecucci C; Piccaluga PP; Petti MC; Rondelli R; Russo D; Sessarego M; Specchia G; Testoni N; Torelli G; Mandelli F; Tura S
    Leukemia; 2001 Jun; 15(6):903-9. PubMed ID: 11417475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haploidentical
    Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
    Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
    Loke J; Labopin M; Craddock C; Cornelissen JJ; Labussière-Wallet H; Wagner-Drouet EM; Van Gorkom G; Schaap NPM; Kröger NM; Veelken JH; Rovira M; Menard AL; Bug G; Bazarbachi A; Giebel S; Brissot E; Nagler A; Esteve J; Mohty M
    Cancer; 2022 Aug; 128(15):2922-2931. PubMed ID: 35612815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation.
    Choi Y; Lee JH; Seo EJ; Lee JH; Kim DY; Park CJ; Jang S; Cho YU; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
    Ann Hematol; 2015 May; 94(5):795-801. PubMed ID: 25563594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The Genetic and Prognostic Characteristics of AML-MRC Patients].
    Chen Z; Mu QT; Wu A; Ouyang GF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):18-21. PubMed ID: 35123598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings.
    Weinberg OK; Ohgami RS; Ma L; Seo K; Ren L; Gotlib JR; Seetharam M; Cherry A; Arber DA
    Am J Clin Pathol; 2014 Aug; 142(2):190-5. PubMed ID: 25015859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the
    Ades L; Prebet T; Stamatoullas A; Recher C; Guieze R; Raffoux E; Bouabdallah K; Hunault M; Wattel E; Stalnikiewicz L; Toma A; Dombret H; Vey N; Sebert M; Gardin C; Chaffaut C; Chevret S; Fenaux P
    Haematologica; 2017 Apr; 102(4):728-735. PubMed ID: 28034993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.
    Kelaidi C; Tzannou I; Baltadakis I; Batsis I; Mallouri D; Spyridonidis A; Gigantes S; Tsirigotis P; Apostolidis I; Athanasiadou A; Manola K; Anagnostopoulos A; Harhalakis N; Sakellari I; Karakasis D
    Bone Marrow Transplant; 2014 Aug; 49(8):1022-8. PubMed ID: 24797183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.